About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

Registration is closed
The Summit has reached full capacity. Registration is closed.
Thanks for your overwhelming response. See you at the 2025 summit!

18th Annual BioPharma & Healthcare Summit,
Thursday, April 25, 2024: 8-15 AM - 6-15 PM

The Newbury Boston Hotel, One Newbury Street, Boston, MA 02116, USA

Chair and Master of Ceremonies (Emcee) - Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
17th annual BioPharma & Healthcare Summit

Virtual Summit
Date: Wednesday, May 3, 2023
Time: 8 AM EST to 4:30 PM EST (Eastern Standard Time)

*Speaker and Timings subject to change
Time Topic
8:00 AM - 8:10 AM Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
8:10 AM - 8:55 AM

Panel: BioPharma R&D and Global Supply Chain agenda at G20

Amitabh Kant, G20 Sherpa, G20
Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

8:55 AM - 9:00 AM Polling + Break
9:00 AM - 9:45 AM Panel: Clinical Trials Opportunities in India

Badhri Srinivasan, Head, Global Clinical Operations, Novartis
Dr. Cynthia Verst, President, Design & Delivery Innovation for R&D Solutions, IQVIA
Dr. Naresh Trehan, Chairman, Medanta - the Medicity
Dr. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
9:45 AM - 9:50 AM Polling + Break
9:50 AM - 10:35 AM Panel: BioPharma Industry & Investment Outlook

Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Christopher Viehbacher, President & CEO, Biogen
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Managing Partner, F-Prime Capital
Theresa Tse, Chairwoman of Board Committee, Sino Biopharmaceutical Limited

Dr. Samuel Waksal, Chairman and Chief Executive Officer, Graviton Biosciences
10:35 AM - 10:40 AM Polling + Break
10:40 AM - 11:20 AM Fireside Chat
Joaquin Duato, Chairman & CEO, Johnson & Johnson

Kenneth Frazier, Chairman, Health Assurance Initiatives, General Catalyst and former Chairman & CEO, Merck & Co.
11:20 AM - 11:25 AM Polling + Break
11:25 AM - 12:00 PM Fireside Chat
Dr. Robert Califf, Commissioner of Food and Drugs, US Food and Drug Administration

Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
12:00 PM - 12:10 PM Polling + Break
12:10 PM - 12:55 PM Panel: Industry Academic Partnerships

Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health
Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk
Dr. Mathai Mammen, CEO Designate, FogPharma
Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen

Dr. Susan Hockfield, President Emerita, MIT
12:55 PM - 1:00 PM Polling + Break
1:00 PM - 1:45 PM Panel: Oncology

Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
Dr. Frank Nestle, Global Head of Research and Chief Scientific Officer, Sanofi
Dr. Kathy Seidl, Vice President, Head of the Oncology Drug Discovery Unit, Takeda
Dr. Katy Rezvani, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research, MD Anderson Cancer Center
Rehan Verjee, Co-Founder & Chief Executive Officer, Stealth start-up

Dr. James Bradner, Physician Scientist, Former President, Novartis Institutes for BioMedical Research
1:45 PM - 1:50 PM Polling + Break
1:50 PM - 2:35 PM Panel: Digital & Data Science

Dr. Alice Zhang, Co-Founder & CEO, Verge Genomics
Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals
Dr. Dina Katabi, Professor of Computer Science, Member - CSAIL, Massachusetts Institute of Technology
Dr. Junaid Bajwa, Chief Medical Scientist, Microsoft
Sastry Chilukuri former Co-CEO, Medidata

Dr. Najat Khan, Chief Data Science Officer and Global Head of Janssen R&D Strategy and Operations, Janssen R&D, Johnson & Johnson
2:35 PM - 2:40 PM Polling + Break
2:40 PM - 3:20 PM Fireside Chat
Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer

Dr. Stelios Papadopoulos, Chairman, Biogen
3:20 PM - 3:25 PM Polling + Break
3-25 PM - 4:10 PM Panel: R&D Strategies and Trends

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
Dr. Daniel Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. Fiona Marshall, President, Novartis Institutes for BioMedical Research

Dr. Martin Mackay, Co-Founder, Rallybio
4:10 PM - 4:15 PM Closing Remarks

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
Pharmasia News BioCentury
© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Media Coverage | Legal | Contact us